Pfizer Recalls One Lot of Anxiety Drug XanaxBy
Pfizer has initiated a voluntary Class II recall of 21,120 bottles of Xanax (alprazolam) tablets, 0.25-mg, 100-count bottle, prescription only, in the United States due to possible subpotency. The recall was initiated on September 24, 2015 and is ongoing, according to the US Food and Drug Administration’s Weekly Enforcement Report of November 4, 2015.
A Class II recall is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The recall applies to one lot (Lot Number C111054; Expiration Date, February 2016).
Xanax is used to anxiety and panic disorder. It contain alprazolam, which is a triazolo analog of the 1,4 benzodiazepine class of central nervous system-active compounds
Source: US Food and Drug Administration